Mindfullnes-Based Cognitive Therapy Effect ([Mindfullnes])
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05995938 |
Recruitment Status :
Completed
First Posted : August 16, 2023
Last Update Posted : August 16, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Mindfullnes-Based Cognitive Therapy and Adherence to Immunosuppressive Therapy | Behavioral: Mindfullnes-Based Cognitive Therapy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 140 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Intervention Model Description: | Experimental |
Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
Primary Purpose: | Basic Science |
Official Title: | Mindfullnes-Based in Surgery Patients for Cognitive Therapy Effect |
Actual Study Start Date : | August 1, 2022 |
Actual Primary Completion Date : | January 1, 2023 |
Actual Study Completion Date : | January 30, 2023 |
Arm | Intervention/treatment |
---|---|
Experimental: Experimental
1
|
Behavioral: Mindfullnes-Based Cognitive Therapy
Mindfullnes-Based Cognitive Therapy Effect on Adherence to Immunosuppressive Therapy in Liver Transplant Recipients
Other Name: [Mindfulness] |
No Intervention: Control
1
|
- The Effect of Mindfulness-Based Cognitive after Liver Transplantation [ Time Frame: Both groups experiment and control. It was used Mindfullnes scale and immunosuppressive terapy adherence scale. It was done measure before and after Mindfullnes-Based Cognitive Therapy. ]It will be measure Therapy on Liver Transplant Recipients' Adherence to Immunosuppressive Therapy
- Mindfullnes-Based Cognitive Therapy [ Time Frame: total of six month.from 1 october 2022 to 30 Jan 2023 ]le level of Mindfulness-Based Cognitive
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Inclusion Criteria involved (i) being a liver transplant recipient, (ii) currently having immunosuppressive treatment, (iii) being 18 years or older (iv) having no language or communication barrier and (v) agreeing to participate in the study.
Liver transplant recipients
Exclusion Criteria:
- The exact opposite of the inclusion criteria the exclusion criteria.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05995938
Turkey | |
the Liver Transplant Hospital affiliated with Turgut Özal Medical Center of İnönü University of Malatya/Turkey. | |
Malatya, Turkey |
Responsible Party: | SEMRA BÜLBÜLOĞLU, Clinical Associate Professor, Istanbul Aydın University |
ClinicalTrials.gov Identifier: | NCT05995938 |
Other Study ID Numbers: |
2022/3884 |
First Posted: | August 16, 2023 Key Record Dates |
Last Update Posted: | August 16, 2023 |
Last Verified: | August 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Liver Recipients Transplantation Mindfulness |